VTMGX

Vanguard Developed Markets Index Admiral

Advertisement

VTMGX Mutual Fund Price & Analysis

This passively managed index fund provides investors with an economical and diversified pathway to invest in large, mid, and small-capitalization companies across developed markets outside of the United States. Given its emphasis on non-U.S. equities, this fund typically experiences higher volatility than investments focused solely on domestic stocks. In addition to general stock market risks, it is also susceptible to currency fluctuations. Furthermore, should a significant portion of its assets be concentrated in a particular country or region, adverse economic conditions there could disproportionately harm the fund's overall performance. This fund can be a valuable consideration for long-term investors seeking to complement a well-rounded domestic equity portfolio.

VTMGX Mutual Fund Chart & Stats

$22.71

-$0.20(-0.87%)

Sep 30, 2026

―

--

VTMGX Mutual Fund News

Cboe data shows mixed options sentiment in SK Hynix Inc – ADR with shares up 0.8%

PremiumThe Fly

Cboe data shows mixed options sentiment in SK Hynix Inc – ADR with shares up 0.8%

6h ago

AstraZeneca Adds Employee Scheme Shares to London Listing

PremiumCompany Announcements

AstraZeneca Adds Employee Scheme Shares to London Listing

9h ago

AstraZeneca Confirms Total Voting Rights and Share Capital Structure

PremiumCompany Announcements

AstraZeneca Confirms Total Voting Rights and Share Capital Structure

9h ago

Shell accelerates share buy-back with cross-market repurchases for cancellation

PremiumCompany Announcements

Shell accelerates share buy-back with cross-market repurchases for cancellation

11h ago

Genentech, Breastcancer.org launch ‘About Damn Time’ campaign

PremiumThe Fly

Genentech, Breastcancer.org launch ‘About Damn Time’ campaign

12h ago

Roche’s Genentech reports new data from Voyager study of Vabysmo

PremiumThe Fly

Roche’s Genentech reports new data from Voyager study of Vabysmo

13h ago

Roche’s Genentech reports detailed results from evERA Breast Cancer study

PremiumThe Fly

Roche’s Genentech reports detailed results from evERA Breast Cancer study

13h ago

Shell Confirms Total Voting Rights and Share Capital Structure

PremiumCompany Announcements

Shell Confirms Total Voting Rights and Share Capital Structure

16h ago

Top 10 Holdings

005930

Samsung Electronics Co Ltd

1.88%

ASML Holding NV

1.77%

000660

SK hynix Inc

1.05%

Novartis

1.01%

AstraZeneca plc

1.01%

Hsbc Holdings Plc (UK)

0.97%

Roche Holding

0.96%

Shell plc (UK)

0.90%

Nestlé

0.87%

Royal Bank Of Canada

0.78%

Total11.20%

Go to Holdings >

Recently Viewed

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Advertisement